2026 Robert D. Schreiber: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	129	237	218	155	140	258	117801
Medicine	129	2518	2346	1418	1301	259	118168

Research.com Recognitions

2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
2013 - Member of the National Academy of Sciences
2010 - Fellow of the American Academy of Arts and Sciences
1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert D. Schreiber is affiliated with Washington University in St. Louis in the United States. Their research spans multiple fields with a focus on medicine and immunology and microbiology. Subfields of particular interest include immunology, oncology, molecular biology, pathology and forensic medicine, and radiology, nuclear medicine and imaging.

The main topics addressed in their research involve immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, immune cell function and interaction, monoclonal and polyclonal antibodies research, cancer genomics and diagnostics, and genetic factors in colorectal cancer.

Notable recent papers by Robert D. Schreiber include:

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020, Cell)
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity (2020, Nature)
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction (2020, Cell)
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads (2021, Proceedings of the National Academy of Sciences)
BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen (2022, Immunity)

Frequent co-authors include Elaine R. Mardis, Philip D. Greenberg, Kenneth M. Murphy, Jasreet Hundal, and Hussein Sultan.

The scientist has published numerous times in venues such as Cancer Immunology Research, Regular and Young Investigator Award Abstracts, arXiv (Cornell University), bioRxiv (Cold Spring Harbor Laboratory), and the Journal of Clinical Oncology.

Throughout their career, Robert D. Schreiber has received several awards, including:

Distinguished Fellows of the American Association of Immunologists (AAI), 2019
Member of the National Academy of Sciences, 2013
Fellow of the American Academy of Arts and Sciences, 2010
Fellow of the American Association for the Advancement of Science (AAAS), 1996

Best Publications

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Robert D. Schreiber;Lloyd J. Old;Mark J. Smyth;Mark J. Smyth

7431
Citations
Cancer immunoediting: from immunosurveillance to tumor escape.

Gavin P. Dunn;Allen T. Bruce;Hiroaki Ikeda;Lloyd J. Old

6710
Citations
How cells respond to interferons

George R. Stark;Ian M. Kerr;Bryan R. G. Williams;Robert H. Silverman

5258
Citations
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

David Hockenbery;Gabriel Nuñez;Curt Milliman;Robert D. Schreiber

5157
Citations
Neoantigens in cancer immunotherapy

Ton N. Schumacher;Robert D. Schreiber

5040
Citations
IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Vijay Shankaran;Hiroaki Ikeda;Allen T. Bruce;J. Michael White

3901
Citations
The three Es of cancer immunoediting.

Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber

3878
Citations
The immunobiology of cancer immunosurveillance and immunoediting

Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber

3740
Citations
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chih Hao Chang;Jing Qiu;David O'Sullivan;Michael D. Buck

3158
Citations
Natural Innate and Adaptive Immunity to Cancer

Matthew D. Vesely;Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth;Mark J. Smyth

2589
Citations
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

Kai Hildner;Brian T. Edelson;Whitney E. Purtha;Mark Diamond

2290
Citations
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

2186
Citations
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

Marco A Meraz;Marco A Meraz;J.Michael White;Kathleen C.F Sheehan;Erika A Bach

2059
Citations
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

Daniel H. Kaplan;Vijay Shankaran;Anand S. Dighe;Elisabeth Stockert

2041
Citations
Interferons, immunity and cancer immunoediting.

Gavin P. Dunn;Catherine M. Koebel;Robert D. Schreiber

1960
Citations
The Molecular Cell Biology of Interferon-gamma and its Receptor

Michael A. Farrar;Robert D. Schreiber

1954
Citations
New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

Deepak Mittal;Matthew M Gubin;Robert D Schreiber;Mark J Smyth;Mark J Smyth

1775
Citations
Adaptive immunity maintains occult cancer in an equilibrium state

Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa

1770
Citations
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

John J O'Shea;Massimo Gadina;Robert D Schreiber

1523
Citations
THE IFN-GAMMA RECEPTOR: A PARADIGM FOR CYTOKINE RECEPTOR SIGNALING

Erika A. Bach;Michel Aguet;Robert D. Schreiber

1489
Citations

Frequent Co-Authors

Mark J. Smyth QIMR Berghofer Medical Research Institute

Lloyd J. Old Ludwig Cancer Research

Jean-Laurent Casanova The University of Texas Southwestern Medical Center

William Vermi University of Brescia

Hans J. Müller-Eberhard Scripps Health

Kenneth M. Murphy Washington University in St. Louis

Emil R. Unanue Washington University in St. Louis

Elaine R. Mardis The Ohio State University

Emmanuelle Jouanguy Necker-Enfants Malades Hospital

Marco Colonna Washington University in St. Louis

External Links

Wikipedia of Robert D. Schreiber Personal website of Robert D. Schreiber

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in Immunology, pursuing related online degrees can open diverse career opportunities. Many professionals start by exploring the best online BSN programs for non nurses to build a strong foundation in nursing and healthcare. These programs offer accessible pathways for individuals beginning their nursing careers without prior experience.

After completing initial nursing credentials, accelerated options like the accelerated FNP programs allow students to fast-track their specialization as family nurse practitioners, blending advanced patient care with immunological knowledge. For nurses aiming to shift focus, obtaining an FNP to acute care certification enhances their ability to manage critically ill patients, integrating immunology with acute care practice.

Finding the right program is essential, and for many, options like accelerated nursing programs near me offer flexible, attainable routes to advance. Together, these related degrees and certifications empower immunology-focused professionals to impact patient outcomes and broaden their healthcare careers.